Data / Form D filings / Encore Vision, Inc.
Encore Vision, Inc.: Form D filings
Encore Vision, Inc., a pharmaceuticals company in Fort Worth, TX, filed 4 Form D notices with the SEC between 2014 and 2016. The latest, on May 13, 2016, reports $4.5 million sold of a $4.5 million offering to 48 investors.
Find out what Encore Vision, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1120 SOUTH FREEWAY, SUITE 118, Fort Worth, TX, 76104
- Phone
- (817) 454-9049
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1618596
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2016 | Amendment | $4,500,000 | $4,500,000 | $0 | 48 | Aug 21, 2015 | sec.gov |
| Aug 25, 2015 | New notice | $2,500,000 | $2,500,000 | $0 | 34 | Aug 21, 2015 | sec.gov |
| Feb 9, 2015 | New notice | $1,116,224 | $1,116,224 | $0 | 22 | Feb 3, 2015 | sec.gov |
| Sep 17, 2014 | New notice | $1,700,000 | $1,680,106 | $19,894 | 29 | Sep 5, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard R. Lindstrom | Director | |
| William R. Burns | Executive Officer, Director | |
| Les R. Kreis | Director | |
| John R. Hunkeler | Director | |
| Adrienne R. Graves | Director | |
| William Ed Tyler | Director | |
| Peter R. Bennett | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of May 9, 2016 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Encore Vision, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.